Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biophan, FDA To Research MRI-Device Compatibility

This article was originally published in The Gray Sheet

Executive Summary

A research partnership between Biophan Technologies and FDA aims to make it safer for patients with implanted medical devices to undergo magnetic resonance imaging (MRI) procedures

You may also be interested in...



CMS Revisits Coverage Policy For MRI In Patients With Cardiac Implants

In response to a formal request, CMS opened a national coverage analysis June 28 for magnetic resonance imaging of patients with pacemakers or defibrillator implants

CMS Revisits Coverage Policy For MRI In Patients With Cardiac Implants

In response to a formal request, CMS opened a national coverage analysis June 28 for magnetic resonance imaging of patients with pacemakers or defibrillator implants

Boston Scientific, Medtronic Heart Devices Go To Panel In March

FDA's Circulatory System Devices advisory panel will weigh in on two closely watched approval decisions at a March 18-19 meeting

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel